350 related articles for article (PubMed ID: 19255163)
1. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome.
Chotikavanich S; de Paiva CS; Li de Q; Chen JJ; Bian F; Farley WJ; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3203-9. PubMed ID: 19255163
[TBL] [Abstract][Full Text] [Related]
2. Corneal epithelial opacity in dysfunctional tear syndrome.
Chen JJ; Rao K; Pflugfelder SC
Am J Ophthalmol; 2009 Sep; 148(3):376-82. PubMed ID: 19541283
[TBL] [Abstract][Full Text] [Related]
3. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.
Luo L; Li DQ; Doshi A; Farley W; Corrales RM; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4293-301. PubMed ID: 15557435
[TBL] [Abstract][Full Text] [Related]
4. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca.
Pflugfelder SC; Jones D; Ji Z; Afonso A; Monroy D
Curr Eye Res; 1999 Sep; 19(3):201-11. PubMed ID: 10487957
[TBL] [Abstract][Full Text] [Related]
5. Correlation of Tear Film Osmolarity and 2 Different MMP-9 Tests With Common Dry Eye Tests in a Cohort of Non-Dry Eye Patients.
Schargus M; Ivanova S; Kakkassery V; Dick HB; Joachim S
Cornea; 2015 Jul; 34(7):739-44. PubMed ID: 25909238
[TBL] [Abstract][Full Text] [Related]
6. Contributions of ocular surface components to matrix-metalloproteinases (MMP)-2 and MMP-9 in feline tears following corneal epithelial wounding.
Petznick A; Madigan MC; Garrett Q; Sweeney DF; Evans MD
PLoS One; 2013; 8(8):e71948. PubMed ID: 23977185
[TBL] [Abstract][Full Text] [Related]
7. Association of tear matrix metalloproteinase 9 immunoassay with signs and symptoms of dry eye disease: A cross-sectional study using qualitative, semiquantitative, and quantitative strategies.
Lee YH; Bang SP; Shim KY; Son MJ; Kim H; Jun JH
PLoS One; 2021; 16(10):e0258203. PubMed ID: 34662364
[TBL] [Abstract][Full Text] [Related]
8. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
[TBL] [Abstract][Full Text] [Related]
9. Neurturin-deficient mice develop dry eye and keratoconjunctivitis sicca.
Song XJ; Li DQ; Farley W; Luo LH; Heuckeroth RO; Milbrandt J; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4223-9. PubMed ID: 14507865
[TBL] [Abstract][Full Text] [Related]
10. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
Messmer EM; von Lindenfels V; Garbe A; Kampik A
Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye.
De Paiva CS; Corrales RM; Villarreal AL; Farley WJ; Li DQ; Stern ME; Pflugfelder SC
Exp Eye Res; 2006 Sep; 83(3):526-35. PubMed ID: 16643899
[TBL] [Abstract][Full Text] [Related]
12. Conjunctivochalasis and Tear Osmolarity Are Associated With Reduced Conjunctival Epithelial Thickness in Dry Eye.
Gumus K; Pflugfelder SC
Am J Ophthalmol; 2021 Jul; 227():35-44. PubMed ID: 33571473
[TBL] [Abstract][Full Text] [Related]
13. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant.
Sobrin L; Liu Z; Monroy DC; Solomon A; Selzer MG; Lokeshwar BL; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1703-9. PubMed ID: 10845589
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Early Changes in Ocular Surface and Inflammatory Mediators between Femtosecond Lenticule Extraction and Small-Incision Lenticule Extraction.
Zhang C; Ding H; He M; Liu L; Liu L; Li G; Niu B; Zhong X
PLoS One; 2016; 11(3):e0149503. PubMed ID: 26937680
[TBL] [Abstract][Full Text] [Related]
15. Effects of azithromycin on gene expression profiles of proinflammatory and anti-inflammatory mediators in the eyelid margin and conjunctiva of patients with meibomian gland disease.
Zhang L; Su Z; Zhang Z; Lin J; Li DQ; Pflugfelder SC
JAMA Ophthalmol; 2015 Oct; 133(10):1117-23. PubMed ID: 26204109
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye.
Pflugfelder SC; Farley W; Luo L; Chen LZ; de Paiva CS; Olmos LC; Li DQ; Fini ME
Am J Pathol; 2005 Jan; 166(1):61-71. PubMed ID: 15632000
[TBL] [Abstract][Full Text] [Related]
17. An enhanced model for environmental dry eye: Exploring pathological features and underlying factors.
Zhao L; Yu JJ; Liu Y; Zuo T; Zhou H; Ju P; Li Y; Cao Y; Dong B
Exp Eye Res; 2024 Feb; 239():109744. PubMed ID: 38072354
[TBL] [Abstract][Full Text] [Related]
18. Essential role for c-Jun N-terminal kinase 2 in corneal epithelial response to desiccating stress.
De Paiva CS; Pangelinan SB; Chang E; Yoon KC; Farley WJ; Li DQ; Pflugfelder SC
Arch Ophthalmol; 2009 Dec; 127(12):1625-31. PubMed ID: 20008718
[TBL] [Abstract][Full Text] [Related]
19. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea.
Afonso AA; Sobrin L; Monroy DC; Selzer M; Lokeshwar B; Pflugfelder SC
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2506-12. PubMed ID: 10509643
[TBL] [Abstract][Full Text] [Related]
20. Conjunctival cytokine expression in symptomatic moderate dry eye subjects.
Narayanan S; Miller WL; McDermott AM
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2445-50. PubMed ID: 16723455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
